Orbital Tumors: Secondary

Secondary Orbital Tumors: Overview - Orbit's Unwanted Guests

• Tumors originating outside the orbit, invading it subsequently.
• Two main pathways:
  • Metastatic Spread: Hematogenous dissemination from distant primary sites.
    • Common primaries: Breast (📌 Breast Beats Bone & Brain/Orbit), Lung, Prostate, Kidney, GI tract.
    • Children: Neuroblastoma, Ewing sarcoma, Wilms tumor.
  • Direct Extension: Invasion from adjacent structures.
    • Paranasal sinuses (most common): Maxillary, ethmoid, sphenoid, frontal.
    • Intracranial: Meningioma, pituitary adenoma.
    • Periorbital skin: Basal cell carcinoma, squamous cell carcinoma, melanoma.

⭐ Differentiate between metastatic spread (hematogenous) and direct extension from adjacent structures (e.g., paranasal sinuses, intracranial).

Secondary Orbital Tumors: Signs & Sleuthing - Eye Spy Trouble

• Red Flags & Presentation:
  • Rapid onset, often unilateral proptosis (axial/non-axial).
  • 📌 DROP-V Symptoms: Diplopia, Rapid proptosis, Ophthalmoplegia, Pain (often severe), Vision loss.
  • Eyelid: Swelling, ptosis, chemosis. Palpable mass.
  • History: Known primary cancer (e.g., breast, lung, prostate).
• Diagnostic Pathway:
  • Imaging is Crucial:
    • CT: Preferred for bone destruction; shows mass, extent.
    • MRI: Superior for soft tissue, perineural spread, intracranial extension.
    • PET-CT: Systemic staging, identify unknown primary.
  • Biopsy: Incisional/FNAC for histopathology (HPE) is gold standard.
  • Systemic workup: To locate primary if unknown (e.g., CXR, mammography).

⭐ Rapid onset of painful proptosis, often with diplopia or visual loss, is a red flag for secondary orbital tumors, especially in patients with a history of malignancy.

Secondary Orbital Tumors: Common Invaders - Rogues' Gallery

• Metastases: 1-13% of orbital tumors. Direct extension also common from paranasal sinuses, intracranial cavity, or eyelids/face.

⭐ In children, neuroblastoma is the most common metastatic orbital tumor, often presenting with bilateral proptosis and periorbital ecchymosis ('raccoon eyes').

Secondary Orbital Tumors: Battle Plan & Fate - Fighting Shadows

• Goal: Palliation, symptom control (pain, proptosis, vision loss), quality of life.
• Treatment Modalities:
  • Radiotherapy: Often primary palliative tool for local control.
  • Chemotherapy: Systemic treatment targeting primary cancer; may shrink orbital metastases.
  • Surgery: Limited role; biopsy, debulking for severe proptosis/optic nerve compression, or solitary accessible metastasis.
  • Hormonal therapy: For hormone-sensitive primaries (e.g., breast, prostate).
• Prognosis: Generally poor, depends on primary tumor type, extent of systemic disease, and patient's overall health.

⭐ Management is often multidisciplinary and palliative, focusing on symptom relief (e.g., radiotherapy for pain/proptosis) and treating the primary malignancy; overall prognosis is generally poor.

• 📌 S.O.S.: Supportive care, Oncology consult, Symptom relief for secondary orbital shadows (tumors).

High‑Yield Points - ⚡ Biggest Takeaways

• Most common primary sites for orbital metastases: Breast (females), Lung (males), Prostate.
• Neuroblastoma: Most common orbital metastasis in children; presents with proptosis, ecchymosis ("raccoon eyes").
• Key features: Rapid, painful proptosis, diplopia, visual loss, ophthalmoplegia.
• Scirrhous breast cancer metastasis can cause enophthalmos (fibrosis).
• Pulsatile proptosis: Suspect renal cell or thyroid carcinoma metastasis.
• Diagnosis: Imaging (CT/MRI) and biopsy for histopathology.
• Orbital metastases signify widespread disease; poor prognosis.